ArticleBMJ open2024

Determining the feasibility of linked claims and vaccination data for a COVID-19 vaccine pharmacoepidemiological study in Germany-RiCO feasibility study protocol.

Nina Timmesfeld et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.